Shanti Inorganics Share Price & Stock Analysis

Quick Answers

What is the Shanti Inorganics share price today? Shanti Inorganics is currently listed and trading. Check our charts for the latest listing performance.

Is Shanti Inorganics a good stock to buy? Review our AI forensic scores and fundamental analysis for Shanti Inorganics to understand the underlying financial health.

Key Stock Information

ViewIPO AI Analysis Score

The Shanti Inorganics Stock scored 58/100 (High Risk) in our deep analysis.

Frequently Asked Questions

What products does Shanti Inorganics manufacture?

Shanti Inorganics manufactures sulphur-based inorganic chemicals including ammonium bisulphite solution, sodium bisulphite powder and solution, sodium metabisulphite, and sodium sulphite powder/anhydrous.

What is the capacity of the company's manufacturing units?

Unit I at Vatva has an installed capacity of 18,800 MTPA; Phase I of Unit II at Bavla commenced commercial production in February 2025 with 18,000 MTPA, and Phase II is under development with a proposed capacity of 78,544 MTPA.

What are the key end‑use industries for the company's chemicals?

The chemicals are used as preservatives, reducing agents, oxygen scavengers, and process intermediates in food and beverages, chemicals, oil drilling, pharmaceuticals, ceramics, agrochemicals, water treatment, petrochemicals, cosmetics, paints, polymers, boilers, and mining.

How has the company's financial performance trended over the last three years?

Revenue grew from ₹44.87 crore in FY24 to ₹57.10 crore in FY25 to ₹71.22 crore in FY26, while profit after tax increased from ₹5.11 crore in FY24 to ₹7.99 crore in FY25 to ₹10.22 crore in FY26.

What are the main risks highlighted in the IPO prospectus?

Key risks include high customer concentration (top 10 customers ~63% of FY26 revenue), reliance on transactional purchase orders without long‑term contracts, exposure to raw material price fluctuations, and outstanding financial indebtedness of ₹34.85 crore.

What is the issue size and price band for the Shanti Inorganics IPO?

The IPO issue size is ₹47.24 crore with a price band of ₹79‑₹83 per share.

View IPO
View IPO
Home›India›Shanti Inorganics ()
Shanti Inorganics Logo

Shanti InorganicsNSE SME / BSE SME:

Analyzed by ViewIPO Financial Research Team
Inorganic ChemicalsIndiaFiled 2026-08-31Listed 2026-09-07Size Pending Data
Listing Price ₹138
Listing Return
₹74.70 (+90%)
Live Subscription
131.83x Total
Check Allotment
Status Link

Is Shanti Inorganics a Good Stock? Quick Verdict

Shanti Inorganics IPO scored 58/100 (High Risk) in our deep analysis. The strongest pillar is Financial at 70/100, while Competition is the primary concern at 45/100. Shanti Inorganics demonstrates strong revenue growth and profitability with diversified export markets, but faces risks from high customer concentration, raw material price volatility, and leverage.

Stock Score
58/100
High Risk

Quick Verdict

Consistent revenue and profit growth, with revenue increasing 26% CAGR from FY24 to FY26.
Geographically diversified export presence, with exports contributing over 50% of revenue in FY26.
Strategic plant location near liquid SO2 sources reduces logistics costs and ensures stable raw material supply.
High customer concentration, with top 10 customers accounting for ~63% of FY26 revenue.
Dependence on transactional purchase orders without long‑term customer contracts increases sales volatility.
Exposure to raw material price fluctuations, as cost of materials consumed represents 38‑45% of income.

Company Snapshot

Revenue (TTM)
₹71.22Cr↑ 24.73% YoY
Profitability
PositiveNet Income ₹10.22Cr
Gross Margin
61.21% 
Market Cap
—Pending Data
Issue Size
— 
Industry
Inorganic Chemicals 
P/E Ratio
—Pending Data

Risk Breakdown

Governance
60
Moderate
Financial
70
Moderate
Valuation
50
Expensive
Competition
45
Expensive
Dilution
60
Moderate
Promoter / Mgmt
60
Moderate

AI Summary

Shanti Inorganics Ltd is engaged in the manufacturing and supply of sulphur-based inorganic chemicals, including ammonium bisulphite, sodium bisulphite, sodium metabisulphite, and sodium sulphite, serving industries such as food and beverages, chemicals, oil drilling, pharmaceuticals, and water treatment. The company operates two manufacturing units in Ahmedabad, Gujarat, with a combined installed capacity of 36,800 MTPA and an upcoming expansion at Bavla to 78,544 MTPA. Financially, revenue grew from ₹44.87 crore in FY24 to ₹71.22 crore in FY26, while profit after tax rose from ₹5.11 crore to ₹10.22 crore over the same period. The IPO seeks to raise ₹47.24 crore at a price band of ₹79‑₹83 per share.

Overall Verdict: Shanti Inorganics demonstrates strong revenue growth and profitability with diversified export markets, but faces risks from high customer concentration, raw material price volatility, and leverage.

Key Highlights

  • •Manufactures sulphur‑based inorganic chemicals (ammonium bisulphite, sodium bisulphite, sodium metabisulphite, sodium sulphite) for diverse end‑use industries.
  • •Two manufacturing units in Ahmedabad, Gujarat; Unit I (Vatva) capacity 18,800 MTPA, Unit II (Bavla) Phase I 18,000 MTPA operational Feb 2025, Phase II under development with 78,544 MTPA proposed.
  • •Holds ISO 9001:2015, NSF, Kosher, HACCP, and Halal certifications, enabling sales in domestic and international markets.
  • •Revenue grew from ₹44.87 crore in FY24 to ₹71.22 crore in FY26 (≈26% CAGR); PAT increased from ₹5.11 crore to ₹10.22 crore over the same period.
  • •Export sales contributed over 50% of revenue in FY26, with presence in markets such as Eswatini, Malaysia, UAE, Qatar, Nigeria, Russia, Colombia, Turkey, Puerto Rico, Iraq, Vietnam, Azerbaijan, Egypt, Ghana, and the Philippines.
  • •The company’s top 10 customers contributed ~63% of FY26 revenue, indicating notable customer concentration risk.

Financial Performance

Revenue (Annual)

↑ +24.7% YoY

INR in Crores

Net Income (Annual)

↑ +27.9% YoY

INR in Crores

Gross Margin (Annual)

↑ +2.0% Delta

In Percentage

EBITDA vs PAT

EBITDA YoY

INR in Crores

EBITDA
PAT

Listing Timeline

IPO Opens2026-08-31
IPO Closes2026-09-02
Basis of Allotment2026-09-03
Refunds & Demat2026-09-04
Listing Date2026-09-07

Valuation Analysis

Issue Price₹79 - ₹83
Estimated Fair Value
Pending Data
Valuation Premium
Pending
vs Fair Value

Stock DNA

Growth
58
Governance
60
Profitability
70
Valuation
50
Competition
45
Execution
60

Pros vs Cons

Pros

  • Consistent revenue and profit growth, with revenue increasing 26% CAGR from FY24 to FY26.
  • Geographically diversified export presence, with exports contributing over 50% of revenue in FY26.
  • Strategic plant location near liquid SO2 sources reduces logistics costs and ensures stable raw material supply.

Cons

  • High customer concentration, with top 10 customers accounting for ~63% of FY26 revenue.
  • Dependence on transactional purchase orders without long‑term customer contracts increases sales volatility.
  • Exposure to raw material price fluctuations, as cost of materials consumed represents 38‑45% of income.

Financial Health

Revenue Growth
26.0% CAGR (FY24-FY26) (Excellent)
Debt Level
₹34.85 crore outstanding financial indebtedness as of May 31, 2026 (Moderate)
Cash & Equivalents
Not disclosed in the prospectus

Institutional Signals

Anchor Investors
Undisclosed
VC Backing Tier
Undisclosed
Strategic Partners
Undisclosed

Shanti Inorganics IPO Reddit Pulse & Sentiment

Real-time Reddit discussions & retail sentiment

No Public Data Available

We couldn't find any significant public discussions or retail sentiment threads for this IPO at the moment.

Disclaimer: These are raw community discussions aggregated from public forums. The AI summary and Reddit comments do not constitute financial advice. Always conduct your own independent research.

Shanti Inorganics Stock — Frequently Asked Questions

Related Stock Reports

Zetwerk

Zetwerk

ZETWERK
55/100
View Report
Shellz India

Shellz India

SHELLZ
0/100
View Report
Bonfiglioli Transmissions

Bonfiglioli Transmissions

BONF
0/100
View Report
Sahajanand Medical Technologies

Sahajanand Medical Technologies

SMT
57/100
View Report
Tonbo Imaging

Tonbo Imaging

TONBO
55/100
View Report
View All Active & Upcoming Stocks & IPOs View Stock & IPO Calendar

Market Terminology Explained

Confused by terms like GMP, Kostak, or Subject to Sauda? Read our detailed guides in the IPO Glossary to understand the terminology before you invest.

Grey Market Premium (GMP)Subject to SaudaASBAOffer for Sale (OFS)
View Full Glossary

Source Citation: All financial data and risk metrics are derived from the official prospectus filed with the regulator (SEBI DRHP/RHP). ViewIPO algorithms process this public data for informational purposes. Not financial advice.

Want to analyze another stock or IPO?

Search any stock, IPO, company, ticker or filing and get instant AI-powered analysis.

Frequently Asked Questions about Shanti Inorganics

What is the expected listing price of Shanti Inorganics?

The expected listing price depends on the live Grey Market Premium. Check the live GMP and expected listing price for Shanti Inorganics on our Live GMP Tracker.